Absci Corporation Common Stock ABSI
$9.71
+0.67%
at last close
Market Cap$1.66 billion
P/E Ratio—
Div Yield—
Volume2.24M
52-Week Range
$2.24$12.05
Analyst Ratings
- Consensus
- Buy — 8 Buy · 0 Hold · 0 Sell (8 analysts)
- Avg. Price Target
- $14.50 (+49.3% upside)
Key Stats
- Today's Range
- $9.50 – $10.15
- 50-Day Range
- $6.69 – $10.62
- 52-Week Range
- $2.24 – $12.05
- Volume
- 2.24 million shs
- Average Volume
- 3.15 million shs
- Market Cap
- $1.66 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 6.73
- Price / Sales
- 1060.91
Short Interest
- Short Interest
- 0.12%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $1.56 million
- Net Income
- $-121,077,000
- Net Margin
- -7756.37%
- Return on Equity
- -49.19%
- Debt-to-Equity
- —
About Absci Corporation Common Stock
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Related Stocks
Compare head-to-head: ABSI vs MEDP·ABSI vs OABI·ABSI vs NRC·ABSI vs BIAF
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.